Approval · Notice of Compliance 35243 · 2025
RYSTIGGO: Notice of Compliance 35243
Issued April 25, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35243
- Date
- April 25, 2025
- Company
- Ucb Canada IncOakville, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYSTIGGO | 02556081 | Marketed |
Medicinal ingredients
- ROZANOLIXIZUMAB 140 MG per ML